Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Bahar Naghavi-Gargari"'
Autor:
Bita Zamani, Mahdieh Mehrab Mohseni, Bahar Naghavi Gargari, Mohammad Taheri, Arezou Sayad, Zeinab Shirvani-Farsani
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Bipolar disorder (BD) patients suffer from severe disability and premature death because of failure in prognosis, diagnosis, and treatment. Although neural mechanisms of bipolar have not been fully discovered, studies have shown long noncodi
Externí odkaz:
https://doaj.org/article/4a70236b2fd14a99a6cf0c1da6f1ebbf
Publikováno v:
Tehran University Medical Journal, Vol 78, Iss 1, Pp 9-15 (2020)
Multiple Sclerosis (MS) is a chronic neurological and inflammatory disorder that affects the nervous system. The etiology of MS is unknown, but genetic and environmental factors are involved in its pathogenesis. There is increasing evidence suggestin
Externí odkaz:
https://doaj.org/article/2b76472af5db4f35ad2b410a0b11457c
Autor:
Shirin Farivar, Roya Amirinejad, Bahar Naghavi gargari, Seyedeh Batool Hassani, Zeinab Shirvani farsani
Publikováno v:
Baghdad Science Journal, Vol 17, Iss 2 (2020)
Vitamin D receptor (VDR) is a nuclear transcription factor that controls gene expression. Its impaired expression was found to be related to different diseases. VDR also acts as a regulator of different pathways including differentiation, inflammatio
Externí odkaz:
https://doaj.org/article/4d70c6a299694a438cb0699413dc927e
Publikováno v:
Precision Medicine and Clinical OMICS. 1
Context: As a contagious acute respiratory disease, COVID-19 was announced by the World Health Organization (WHO) as a pandemic on 11 March 2020. The clinical manifestation of COVID-19 includes fever, cough, taste/smell loss, and acute respiratory di
Autor:
Alireza Zahirodin, Jamal Shams, Zeinab Shirvani Farsani, Bahar Naghavi Gargari, Sayyed Mohammad Hossein Ghaderian
Publikováno v:
Metabolic Brain Disease. 35:1077-1083
Bipolar disorders are known as chronic, recurrent, and heterogenic diseases. Regarding, diagnosis and treatment of them are very complex. The molecular mechanism and pathophysiology of bipolar disorder are slightly known. Accordingly, long noncoding
Autor:
Maryam Ahani, Sayyed Mohammad Hossein Ghaderian, Mitra Mehr Azma, Koosha Kamali, Bahar Naghavi Gargari, Samaneh Vojdani
Publikováno v:
International Journal of Cancer Management. 15
Background: Prostate cancer (PCa) and benign prostate hyperplasia (BPH) are highly prevalent heterogeneous disorders among men. Since angiogenesis is the key step in cancer progression, the deregulation of genes involved in this process may play a ro
Autor:
Maryam Ahani, Sayyed Mohammad Hossein Ghaderian, Mitra Mehr Azma, Koosha Kamali, Bahar Naghavi Gargari, Golnaz Bahramali, Reza Akbarzadeh
Publikováno v:
Andrologia. 54
Prostate cancer (PCa) and benign prostate hyperplasia (BPH) are highly prevalent heterogeneous disorders among men. Whereas PCa and BPH underline common pathological features, apoptotic-related genes might be differentially expressed in these disease
Autor:
Sayyed Mohammad Hossein Ghaderian, Bahar Naghavi-Gargari, Zeinab Shirvani-Farsani, Alireza Zahirodin
Publikováno v:
Neuroscience Letters. 696:206-211
Bipolar disorder (BD) is a mental disorder that is often misdiagnosed with ineffective treatment. It has strong genetic component but unknown pathophysiology. Long non-coding RNAs (lncRNAs) have been recently recognized as one of the important geneti
Autor:
Farbod Taghavi, Rad, Bahar Naghavi, Gargari, Saied, Ghorbian, Zeinab Shirvani, Farsani, Rasoul, Sharifi
Publikováno v:
Gene. 828:146477
CRISPR-Cas9 gene-editing technology has pushed the boundaries of genetic modification. The principle of this method is based on the purposeful defense system of DNA degradation and will be one of the most powerful instruments for gene editing shortly
Autor:
Abdorreza Naser Moghadasi, Amir Reza Azimi, Mehrdad Behmanesh, Majid Pahlevan Kakhki, Roozita Doosti, Bahar Naghavi Gargari, Zeinab Shirvani-Farsani
Publikováno v:
Neuroscience letters. 653
Background and purpose The aim of this study was to investigate the expression levels of vitamin D receptor (VDR) and NF-κB mRNAs in vitamin D (VD) supplemented multiple sclerosis (MS) patients. Methods RRMS patients received 50,000 IU vitamin D3/we